Medical and health researchers

Paul J. Utz

Paul J. Utz is a professor of immunology and rheumatology at Stanford University School of Medicine, known for developing autoantigen microarrays to study autoimmune diseases.

Paul J. van der Maas

Paul J. van der Maas, full name Paul Johan van der Maas, was a Dutch public-health researcher at Erasmus University Rotterdam whose national euthanasia studies informed Dutch policy.

Paul J. Wiesner

Paul J. Wiesner (1940–2025) was an American physician and Public Health Service officer whose CDC gonorrhea research shaped national treatment policy from the 1970s onward.

Paul Janssen (1926–2003) was a Belgian physician and pharmacologist who founded Janssen Pharmaceutica, merged it with Johnson & Johnson in 1961, and developed more than 70 medicines, including haloperidol, fentanyl, and mebendazole.

Paul K. Whelton

Paul K. Whelton (Paul Whelton) is an Irish-born American physician-scientist at Tulane University who led NIH trials including SPRINT and chaired the 2017 ACC/AHA guideline redefining high blood pressure.

Paul Kallós

Paul Kallós (1902–1988) was a Hungarian-born Swedish physician and allergist who pioneered the concept of pseudo-allergic reactions and founded the International Archives of Allergy and Applied Immunology.

Paul Khairy

Paul Khairy is a Canadian cardiologist and electrophysiologist at the Montreal Heart Institute, known for establishing arrhythmias in adult congenital heart disease as a subspecialty.

Paul Klenerman

Paul Klenerman is a physician-scientist who holds the Sidney Truelove Professorship of Gastroenterology at Oxford, known for work on T-cell failure in chronic infection and hepatitis C vaccine trials.

Paul Kubes

Paul Kubes is a Canadian immunologist at the University of Calgary known for using intravital microscopy to image how neutrophils and macrophages fight bacteria in living tissue.

Paul L. Kimmel

Paul L. Kimmel is an American nephrologist and program director at the NIDDK, known for research on kidney disease in HIV infection and his 2014 review of acute and chronic kidney disease.

Paul L. Padfield

Paul L. Padfield is a physician-scientist known for hypertension research, from vasopressin studies at the MRC Blood Pressure Unit in Glasgow to home blood pressure monitoring in Edinburgh.

Paul Lichtenstein

Paul Lichtenstein is a Swedish genetic epidemiologist and professor at Karolinska Institutet in Stockholm, known for the 2012 New England Journal of Medicine study linking ADHD medication to lower criminality.

Paul Little (physician)

Paul Little is a British general practitioner and Professor of Primary Care Research at the University of Southampton, known for trials reducing antibiotic prescribing for respiratory infections.

Paul M. Aggeler

Paul M. Aggeler (1911–1969) was an American hematologist and professor of medicine at UCSF who discovered Factor IX deficiency, now called hemophilia B, and first described hereditary warfarin resistance.

Paul M. Hwang

Paul M. Hwang is an American physician-scientist who leads the Cardiovascular and Cancer Genetics laboratory at the National Heart, Lung, and Blood Institute, studying p53 and mitochondrial metabolism in cancer.

Paul M. Lieberman

Paul M. Lieberman is an American virologist and epigenetics researcher at The Wistar Institute in Philadelphia who studies latent Epstein-Barr virus infection and EBNA1 inhibitors.

Paul M. Matthews

Paul M. Matthews is a neurologist who founded Oxford's FMRIB brain imaging center, worked in imaging research at GlaxoSmithKline, and studies neuroinflammation in Alzheimer's disease and multiple sclerosis.

Paul M. O’Byrne

Paul M. O'Byrne is an Irish-born Canadian physician-scientist at McMaster University whose research established airway inflammation as central to asthma, and who led the SYGMA trials changing mild asthma treatment.

Paul M. Ridker

Paul M. Ridker is an American cardiovascular researcher, Eugene Braunwald Professor at Harvard Medical School, who established the role of inflammation in heart disease prevention and treatment.

Paul M. Stewart

Paul M. Stewart is a British endocrinologist and Emeritus Professor of Medicine at the University of Leeds, known for research on corticosteroid hormones, Cushing's syndrome, and hypertension.

Paul M. Thompson

Paul M. Thompson is a neuroscientist and professor at the University of Southern California who co-founded the ENIGMA Consortium, a worldwide alliance of brain-imaging scientists studying brain diseases.

Paul McKeigue

Paul McKeigue is a physician-scientist and professor of genetic epidemiology and statistical genetics at the University of Edinburgh since 2007, known for his 1991 Lancet study of insulin resistance in South Asians.

Paul Meier (statistician)

Paul Meier (1924–2011) was an American statistician who co-developed the Kaplan–Meier estimator, the standard method for estimating survival from incomplete medical data, and championed randomized clinical trials.

Paul Moayyedi

Paul Moayyedi is a gastroenterologist and Professor of Medicine at McMaster University in Hamilton, Ontario, known for his 2000 Lancet trial of population H. pylori screening.

Paul Muntner

Paul Muntner is an American cardiovascular epidemiologist known for blood pressure measurement and hypertension control, whose 2017 analysis estimated 103.3 million US adults had hypertension under the ACC/AHA guideline.

Paul N. Durrington

Paul N. Durrington, also known as Paul Durrington, is a British physician-scientist in lipid disorders who pioneered cascade family screening for familial hypercholesterolaemia and led the CARDS statin trial.

Paul N. Maton

Paul N. Maton, also cited as P. N. Maton, is a British-trained gastroenterologist known for research on Zollinger–Ellison syndrome, omeprazole, and octreotide at NIH and in Oklahoma.

Paul N. Yu

Paul N. Yu, born Paul Nan-Gan Yu, was a Chinese-born American cardiologist who built the University of Rochester's cardiology unit and was American Heart Association president in 1972.

Paul Negulescu

Paul Negulescu is a cell biologist and Vertex Pharmaceuticals Senior Vice President in San Diego who led discovery of the CFTR modulators treating cystic fibrosis, winning the 2024 Breakthrough Prize and the 2025 Lasker~DeBakey Award.